FDA Should Consider Costs in Some Decisions
The following guest post comes from Steve Grossman, who works to increase…
MelaFind Gets FDA Approval For Detecting Melanoma
This has been a long haul for Melafind as back in November…
A Victory for Coverage with Evidence Development
A federal study of a new stent designed to prevent repeat strokes…
FDA Has A New Training Program for Medical Device Reviewers
This is good thing and it’s the same process that should and…
FDA Criticized for Lack of Controls over Increasing Prescription Narcotic Abuse
The rise in prescription drug abuse in this country has been muted…
FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
Cancer drugs certainly are not cheap and for a year, this one…
Alternatives to Scrapping 510(k)
The Institute of Medicine report on medical device regulation released two weeks…
Unintended Consequences of Changing the Current 510K System for “Moderate Risk” Devices
On July 29 an expert panel assembled by the Institute…
Legal Concerns: What Steps can Pharma Take to Engage in Social Media?
. This is the second part of a three part post addressing…
Bio-Rad receives pre-market approval for HIV test from FDA
Bio-Rad Laboratories (NYSE:BIO) announced Monday it received FDA premarket approval for its…
